{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:07:23Z","timestamp":1774620443571,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270206"],"award-info":[{"award-number":["82270206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LZ22H160009"],"award-info":[{"award-number":["LZ22H160009"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Project of the Zhejiang Higher Education Association's Special Project on \"Smart Education and Digital Transformation of Teaching\"","award":["KT2023416"],"award-info":[{"award-number":["KT2023416"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-026-00739-6","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:33:23Z","timestamp":1771493603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic role of whole blood Epstein\u2011Barr virus DNA load in angioimmunoblastic T-cell lymphoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Yi","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengmeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangshu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baodong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"9","key":"739_CR1","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1182\/blood-2016-09-692541","volume":"129","author":"MA Lunning","year":"2017","unstructured":"Lunning MA, Vose JM. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood. 2017;129(9):1095\u2013102.","journal-title":"Blood"},{"issue":"1","key":"739_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ajcp\/aqab090","volume":"156","author":"Y Xie","year":"2021","unstructured":"Xie Y, Jaffe ES, How I, Diagnose Angioimmunoblastic. T-Cell lymphoma. Am J Clin Pathol. 2021;156(1):1\u201314.","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"739_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720\u201348.","journal-title":"Leukemia"},{"issue":"9","key":"739_CR4","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","volume":"111","author":"N Mourad","year":"2008","unstructured":"Mourad N, Mounier N, Bri\u00e8re J, et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the groupe d\u2019etude des lymphomes de l\u2019adulte (GELA) trials. Blood. 2008;111(9):4463\u201370.","journal-title":"Blood"},{"issue":"9","key":"739_CR5","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.3324\/haematol.2015.126300","volume":"100","author":"L De Leval","year":"2015","unstructured":"De Leval L, Parrens M, Le Bras F, et al. Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets. Haematologica. 2015;100(9):e361\u20134.","journal-title":"Haematologica"},{"issue":"12","key":"739_CR6","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1182\/blood-2011-08-374371","volume":"119","author":"T Tokunaga","year":"2012","unstructured":"Tokunaga T, Shimada K, Yamamoto K, et al. Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan. Blood. 2012;119(12):2837\u201343.","journal-title":"Blood"},{"issue":"2","key":"739_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M, et al. Clinicopathologic characteristics of angioimmunoblastic T-Cell lymphoma: analysis of the international peripheral T-Cell lymphoma project. JCO. 2013;31(2):240\u20136.","journal-title":"JCO"},{"issue":"10","key":"739_CR8","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","volume":"34","author":"S Chiba","year":"2020","unstructured":"Chiba S, Sakata-Yanagimoto M. Advances in Understanding of angioimmunoblastic T-cell lymphoma. Leukemia. 2020;34(10):2592\u2013606.","journal-title":"Leukemia"},{"issue":"25","key":"739_CR9","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"T International","year":"2008","unstructured":"International T-, Cell Lymphoma Project. International peripheral T-Cell and natural Killer\/T-Cell lymphoma study: pathology findings and clinical outcomes. JCO. 2008;26(25):4124\u201330.","journal-title":"JCO"},{"issue":"18","key":"739_CR10","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","volume":"116","author":"N Schmitz","year":"2010","unstructured":"Schmitz N, Tr\u00fcmper L, Ziepert M, et al. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin lymphoma study group. Blood. 2010;116(18):3418\u201325.","journal-title":"Blood"},{"issue":"25","key":"739_CR11","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","volume":"30","author":"F d\u2019Amore","year":"2012","unstructured":"d\u2019Amore F, Relander T, Lauritzsen GF, et al. Up-Front autologous Stem-Cell transplantation in peripheral T-Cell lymphoma: NLG-T-01. JCO. 2012;30(25):3093\u20139.","journal-title":"JCO"},{"issue":"7","key":"739_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI. Epstein\u2013Barr virus infection. N Engl J Med. 2000;343(7):481\u201392.","journal-title":"N Engl J Med"},{"issue":"6","key":"739_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.semcancer.2009.07.002","volume":"19","author":"GW Bornkamm","year":"2009","unstructured":"Bornkamm GW. Epstein-Barr virus and its role in the pathogenesis of burkitt\u2019s lymphoma: an unresolved issue. Semin Cancer Biol. 2009;19(6):351\u201365.","journal-title":"Semin Cancer Biol"},{"issue":"23","key":"739_CR14","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","volume":"118","author":"R Suzuki","year":"2011","unstructured":"Suzuki R, Yamaguchi M, Izutsu K, et al. Prospective measurement of Epstein-Barr virus\u2013DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type. Blood. 2011;118(23):6018\u201322.","journal-title":"Blood"},{"issue":"7","key":"739_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood.2019000568","volume":"134","author":"PG Murray","year":"2019","unstructured":"Murray PG, Young LS. An etiological role for the Epstein-Barr virus in the pathogenesis of classical hodgkin lymphoma. Blood. 2019;134(7):591\u20136.","journal-title":"Blood"},{"issue":"1","key":"739_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1365-2141.2007.06620.x","volume":"138","author":"Y Zhou","year":"2007","unstructured":"Zhou Y, Attygalle AD, Chuang S-S, et al. Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load. Br J Haematol. 2007;138(1):44\u201353.","journal-title":"Br J Haematol"},{"issue":"12","key":"739_CR17","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.3390\/cancers14122899","volume":"14","author":"R Bahri","year":"2022","unstructured":"Bahri R, Boyer F, Halabi MA, et al. Epstein-Barr virus (EBV) is mostly latent and clonal in angioimmunoblastic T cell lymphoma (AITL). Cancers. 2022;14(12):2899.","journal-title":"Cancers"},{"key":"739_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-62703-357-2_16","volume":"999","author":"LM Weiss","year":"2013","unstructured":"Weiss LM, Chen Y-Y. EBER in situ hybridization for Epstein-Barr virus. Methods Mol Biol. 2013;999:223\u201330.","journal-title":"Methods Mol Biol"},{"issue":"9","key":"739_CR19","doi-asserted-by":"publisher","first-page":"e608","DOI":"10.1038\/bcj.2017.88","volume":"7","author":"J-H Liang","year":"2017","unstructured":"Liang J-H, Wang L, Peter Gale R, et al. Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer\/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA. Blood Cancer J. 2017;7(9):e608\u2013608.","journal-title":"Blood Cancer J"},{"issue":"3","key":"739_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3109\/10428194.2015.1072766","volume":"57","author":"MC Tisi","year":"2016","unstructured":"Tisi MC, Cupelli E, Santangelo R, et al. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma. Leuk Lymphoma. 2016;57(3):628\u201334.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"739_CR21","doi-asserted-by":"publisher","first-page":"e0199398","DOI":"10.1371\/journal.pone.0199398","volume":"13","author":"X Gao","year":"2018","unstructured":"Gao X, Li J, Wang Y, et al. Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: A meta-analysis. PLoS ONE. 2018;13(6):e0199398.","journal-title":"PLoS ONE"},{"issue":"7","key":"739_CR22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ajh.26579","volume":"97","author":"L Malpica","year":"2022","unstructured":"Malpica L, Marques-Piubelli ML, Beltran BE, et al. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk-stratification, and management. Am J Hematol. 2022;97(7):951\u201365.","journal-title":"Am J Hematol"},{"issue":"1","key":"739_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4143\/crt.2017.476","volume":"51","author":"J-H Liang","year":"2019","unstructured":"Liang J-H, Lu L, Zhu H-Y, et al. The prognostic role of Circulating Epstein-Barr virus DNA copy number in angioimmunoblastic T-Cell lymphoma treated with Dose-Adjusted EPOCH. Cancer Res Treat. 2019;51(1):150\u20137.","journal-title":"Cancer Res Treat"},{"issue":"20","key":"739_CR24","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","journal-title":"Blood"},{"issue":"4","key":"739_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00432-024-05702-9","volume":"150","author":"J Chen","year":"2024","unstructured":"Chen J, Zhou J, Cheng F, et al. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma. J Cancer Res Clin Oncol. 2024;150(4):181.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"14","key":"739_CR26","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","unstructured":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;329(14):987\u201394.","journal-title":"N Engl J Med"},{"issue":"7","key":"739_CR27","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004;103(7):2474\u20139.","journal-title":"Blood"},{"issue":"3","key":"739_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1182\/blood.2020010387","volume":"138","author":"RH Advani","year":"2021","unstructured":"Advani RH, Skrypets T, Civallero M, et al. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell project. Blood. 2021;138(3):213\u201320.","journal-title":"Blood"},{"issue":"2","key":"739_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/sim.4780030207","volume":"3","author":"FE Harrell","year":"1984","unstructured":"Harrell FE, Lee KL, Califf RM, et al. Regression modelling strategies for improved prognostic prediction. Stat Med. 1984;3(2):143\u201352.","journal-title":"Stat Med"},{"issue":"4","key":"739_CR30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/leu.2013.212","volume":"28","author":"Y-L Kwong","year":"2014","unstructured":"Kwong Y-L, Pang AWK, Leung AYH, et al. Quantification of Circulating Epstein-Barr virus DNA in NK\/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance. Leukemia. 2014;28(4):865\u201370.","journal-title":"Leukemia"},{"issue":"2","key":"739_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ijc.33802","volume":"150","author":"Z Shen","year":"2022","unstructured":"Shen Z, Hu L, Yao M, et al. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai lymphoma working group. Int J Cancer. 2022;150(2):327\u201334.","journal-title":"Int J Cancer"},{"issue":"1","key":"739_CR32","doi-asserted-by":"publisher","first-page":"2478315","DOI":"10.1080\/07853890.2025.2478315","volume":"57","author":"C-Y Chan","year":"2025","unstructured":"Chan C-Y, Lin T-L, Kuo M-C, et al. Prognostic impact of pre-treatment and post-treatment plasma Epstein-Barr virus DNA in peripheral T-cell lymphomas. Ann Med. 2025;57(1):2478315.","journal-title":"Ann Med"},{"issue":"2","key":"739_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000516588","volume":"145","author":"D Zhao","year":"2022","unstructured":"Zhao D, Hu S, Zhou D, et al. Clinical significance of plasma Epstein-Barr virus DNA in peripheral T-Cell lymphomas. Acta Haematol. 2022;145(2):132\u201343.","journal-title":"Acta Haematol"},{"issue":"10","key":"739_CR34","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1080\/10428194.2017.1300894","volume":"58","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zheng X, Chen B, et al. The clinical significance of Epstein-Barr virus DNA in peripheral blood mononuclear cells in patients with non-Hodgkin lymphoma. Leuk Lymphoma. 2017;58(10):2349\u201355.","journal-title":"Leuk Lymphoma"},{"key":"739_CR35","doi-asserted-by":"publisher","first-page":"797028","DOI":"10.3389\/fonc.2021.797028","volume":"11","author":"T-Y Kim","year":"2021","unstructured":"Kim T-Y, Min G-J, Jeon Y-W, et al. Impact of Epstein-Barr virus on peripheral T-Cell lymphoma not otherwise specified and angioimmunoblastic T-Cell lymphoma. Front Oncol. 2021;11:797028.","journal-title":"Front Oncol"},{"issue":"10","key":"739_CR36","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2012-06-435024","volume":"120","author":"Z-Y Wang","year":"2012","unstructured":"Wang Z-Y, Liu Q-F, Wang H, et al. Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK\/T-cell lymphoma patients receiving primary radiotherapy. Blood. 2012;120(10):2003\u201310.","journal-title":"Blood"},{"issue":"8","key":"739_CR37","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/ijc.30566","volume":"140","author":"BM Haverkos","year":"2017","unstructured":"Haverkos BM, Huang Y, Gru A, et al. Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas. Int J Cancer. 2017;140(8):1899\u2013906.","journal-title":"Int J Cancer"},{"issue":"1","key":"739_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","volume":"104","author":"W-Y Au","year":"2004","unstructured":"Au W-Y, Pang A, Choy C, et al. Quantification of Circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood. 2004;104(1):243\u20139.","journal-title":"Blood"},{"issue":"4","key":"739_CR39","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/cancers13040610","volume":"13","author":"N Bayda","year":"2021","unstructured":"Bayda N, Tilloy V, Chaunavel A, et al. Comprehensive Epstein-Barr virus transcriptome by RNA-Sequencing in angioimmunoblastic T cell lymphoma (AITL) and other lymphomas. Cancers (Basel). 2021;13(4):610.","journal-title":"Cancers (Basel)"},{"issue":"54","key":"739_CR40","doi-asserted-by":"publisher","first-page":"92312","DOI":"10.18632\/oncotarget.21251","volume":"8","author":"YR Kim","year":"2017","unstructured":"Kim YR, Kim S-J, Cheong J-W, et al. Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma. Oncotarget. 2017;8(54):92312\u201323.","journal-title":"Oncotarget"},{"issue":"16","key":"739_CR41","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","volume":"127","author":"JA Kanakry","year":"2016","unstructured":"Kanakry JA, Hegde AM, Durand CM, et al. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. 2016;127(16):2007\u201317.","journal-title":"Blood"},{"issue":"2","key":"739_CR42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1600-6143.2008.02514.x","volume":"9","author":"JK Preiksaitis","year":"2009","unstructured":"Preiksaitis JK, Pang XL, Fox JD, et al. Interlaboratory comparison of epstein-barr virus viral load assays. Am J Transpl. 2009;9(2):269\u201379.","journal-title":"Am J Transpl"},{"issue":"6","key":"739_CR43","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cmi.2015.02.017","volume":"21","author":"J-H Liang","year":"2015","unstructured":"Liang J-H, Lu T-X, Tian T, et al. Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma. Clin Microbiol Infect. 2015;21(6):596\u2013602.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"739_CR44","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/cam4.2742","volume":"9","author":"AE Eladl","year":"2020","unstructured":"Eladl AE, Shimada K, Suzuki Y, et al. EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma. Cancer Med. 2020;9(2):678\u201388.","journal-title":"Cancer Med"},{"issue":"10","key":"739_CR45","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3324\/haematol.2011.061507","volume":"97","author":"M-H Delfau-Larue","year":"2012","unstructured":"Delfau-Larue M-H, De Leval L, Joly B, et al. Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA. Haematologica. 2012;97(10):1594\u2013602.","journal-title":"Haematologica"},{"issue":"9","key":"739_CR46","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1158\/1078-0432.CCR-10-3327","volume":"17","author":"S Hohaus","year":"2011","unstructured":"Hohaus S, Santangelo R, Giachelia M, et al. The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in hodgkin lymphoma. Clin Cancer Res. 2011;17(9):2885\u201392.","journal-title":"Clin Cancer Res"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-026-00739-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00739-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00739-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:01:50Z","timestamp":1774616510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13027-026-00739-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1186\/s13027-026-00739-6","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the institutional review board at the coordinating center (The First Affiliated Hospital of Medical School, Zhejiang University, Hangzhou, China) and at each participating center as per the institutional standard. The patients provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the individuals for the publication of any potentially identifiable images or data included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}